ArticleSystematic reviews2025
How to quantify between-study heterogeneity in single-arm evidence synthesis?-It depends!
Article in Systematic reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled safety profiles of bispecific antibodies targeting PD-1/CTLA-4 or PD-1/VEGF in non-small cell lung cancer: a systematic review and single-arm meta-analysis.Journal of the Egyptian National Cancer Institute · 2026Pooled it
- The efficacy and safety of tislelizumab in the treatment of locally advanced or metastatic lung cancer: a systematic review and meta-analysis.Frontiers in pharmacology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRandom-effects meta-analysis models account for between-study heterogeneity by estimating and incorporating the heterogeneity variance parameter
methodsWe compared seven heterogeneity variance estimators for random-effects meta-analysis. The estimators were selected on the basis of methodological diversity and availability and were evaluated both empirically and in a simulation study. We simulated typical meta-analysis scenarios for continuous and binary outcomes in a single-arm meta-analysis setting. Through a non-systematic literature review, we assessed which heterogeneity variance estimators are currently used in high-ranked journals, and evaluated their reporting quality.
resultsOur simulation study showed that all evaluated heterogeneity estimators were imprecise and often failed to estimate the true amount of heterogeneity. The estimation is particularly imprecise in situations where the meta-analysis contained few studies or when the binary outcomes included rare events. Moreover, we discovered that most heterogeneity variance estimators produce zero heterogeneity estimates under all simulated conditions, even though heterogeneity was present. The estimated overall effect was found to be relatively robust to different estimators in the empirical application and in our simulation study. However, the prediction intervals for the overall effect vary depending on the estimator chosen.
conclusionsAlthough different heterogeneity variance estimators produce substantially different heterogeneity variance estimates, too little attention is paid to selecting a suitable heterogeneity variance estimator in single-arm evidence synthesis. Based on our literature review, we conclude that the awareness of different heterogeneity variance estimators and their properties needs to be strengthened in practice. Given that it is rarely appropriate to rely on a single heterogeneity variance estimator, we suggest careful consideration and evaluation of a wider range of plausible estimators in a sensitivity analysis before drawing a final conclusion about the meta-analysis results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.